Ms Medication

If you’ve ever wondered how new Multiple Sclerosis drugs are developed, evaluated, and finally approved for the market, Bloomberg.com offers a link to the video of the FDA Committee Meeting on Novartis’s new Gilenia, the first pill for Multiple Sclerosis. After drug testing and before the FDA approves a new medication, a panel of health […]

Continue reading about Gilenia, MS Pill, Recommended for Approval by Panel

Rick on April 11th, 2010

Ampyra [am-PEER-ah], the brand name for a new drug named fampridine-SR, has been approved by the US Food and Drug Administration for the treatment of Multiple Sclerosis. The new drug is the first Multiple Sclerosis drug to enhance some neurological functioning for MS patients. Dr. Andrew Goodman, chief of the University of Rochester Medical Center’s […]

Continue reading about Ampyra, A New Multiple Sclerosis Drug with Promise

Rick on February 28th, 2009

You may think your pharmaceutical expenses and drug costs are high. They are. Part of the reason is that drugs are made by corporations that must return value to shareholders. To do this, they must sell drugs. To sell drugs, pharmaceutical companies have paid doctors to promote their drugs. The money paid to doctors is […]

Continue reading about Drug Companies Pay Doctors

css.php